SCHEMBL20737287

SCHEMBL20737287

c1ccc(-c2cccc(-c3ccccc3-c3cc4c(c5ccccc35)-c3cc5ccccc5cc3C43c4ccccc4-c4ccccc43)n2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
CCR1 P32246 3/20 0.41
CCR5 P51681 3/20 0.41
CCR8 P51685 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 3/20 0.41
TP53 P04637 2/20 0.41
MAPK1 P28482 2/20 0.41
ALPL P05186 1/20 0.41
HSP90AA1 P07900 1/20 0.41
ALPI P09923 1/20 0.41
ALPG P10696 1/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDK2 Q15119 1/20 0.36
NPC1 O15118 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737209 0.95 KDM4E (0.43) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL20737219 0.89 PDK2 (0.40) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL20737283 0.88 PDK2 (0.39) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL20737070 0.88 KDM4E (0.40) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL20737175 0.87 KDM4E (0.39) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL27250710 0.85 PDK2 (0.38) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL20736938 0.85 KDM4E (0.42) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL27250686 0.85 PDK2 (0.44) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL20737273 0.84 PDK2 (0.42) KDM4ECCR1CCR5CCR8SMN1; SMN2
SCHEMBL20737775 0.84 LMNA (0.35) KDM4ECCR1CCR5CCR8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885CCR1 1730/4885CCR5 3344/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 KDM4E 2169/4885CCR1 1730/4885CCR5 3344/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885CCR1 1730/4885CCR5 3344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.